The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Epidemiology, classification, and modifiable risk factors of peripheral arterial disease
Open accessAbstract
Peripheral arterial disease (PAD) is part of a global vascular problem of diffuse atherosclerosis. PAD patients die mostly of cardiac and cerebrovascular-related events and much less frequently due to obstructive disease of the lower extremities. Aggressive risk factors modification is needed to reduce cardiac mortality in PAD patients. These include smoking cessation, reduction of blood pressure to current guidelines, aggressive low density lipoprotein lowering, losing weight, controlling diabetes and the use of oral antiplatelet drugs such as aspirin or clopidogrel. In addition to quitting smoking and exercise, cilostazol and statins have been shown to reduce claudication in patients with PAD. Patients with critical rest limb ischemia or severe progressive claudication need to be treated with revascularization to minimize the chance of limb loss, reduce symptoms, and improve quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Recommended standards for reports dealing with lower extremity ischemia: Revised version
Rutherford, R. B., Baker, J. D., Ernst, C., Johnston, K. W., Porter, J. M., Ahn, S., & Jones, D. N. (1997) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(97)70045-4 · Cited by 3,562
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
Criqui, M. H., Langer, R. D., Fronek, A., Feigelson, H. S., Klauber, M. R., McCann, T. J., & Browner, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202063260605 · Cited by 2,579
Selvin, E., & Erlinger, T. P. (2004) · Circulation · doi:10.1161/01.cir.0000137913.26087.f0 · Cited by 1,885
Dormandy, J., & Rutherford, R. B. (2000) · PubMed · Cited by 1,635
Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,296
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
Weitz, J. I., Byrne, J., Clagett, G. P., Farkouh, M. E., Porter, J. M., Sackett, D. L., Strandness, D. E., & Taylor, L. M. (1996) · Circulation · doi:10.1161/01.cir.94.11.3026 · Cited by 889
Hiatt, W. R., Hoag, S., & Hamman, R. F. (1995) · Circulation · doi:10.1161/01.cir.91.5.1472 · Cited by 551
Benefit of exercise conditioning for patients with peripheral arterial disease.
Hiatt, W. R., Regensteiner, J. G., Hargarten, M. E., Wolfel, E. E., & Brass, E. P. (1990) · Circulation · doi:10.1161/01.cir.81.2.602 · Cited by 509
A comparison of cilostazol and pentoxifylline for treating intermittent claudication
Dawson, D. L., Cutler, B. S., Hiatt, W. R., Hobson, R. W., Martin, J. D., Bortey, E. B., Forbes, W. P., & Strandness, D. E. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00569-6 · Cited by 443
Price, J. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1194 · Cited by 396
Fate in intermittent claudication: outcome and risk factors.
Jelnes, R., Gaardsting, O., Hougaard Jensen, K., Baekgaard, N., Tonnesen, K. H., & Schroeder, T. (1986) · BMJ · doi:10.1136/bmj.293.6555.1137 · Cited by 299
Marston, W. A., Davies, S. W., Armstrong, B., Farber, M. A., Mendes, R. C., Fulton, J. J., & Keagy, B. A. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.03.026 · Cited by 280
Mondillo, S., Ballo, P., Barbati, R., Guerrini, F., Ammaturo, T., Agricola, E., Pastore, M., Borrello, F., Belcastro, M., Picchi, A., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00010-x · Cited by 266
Ness, J., & Aronow, W. S. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb05208.x · Cited by 257
Intermittent claudication — its natural course
(1976) · Journal of the American College of Emergency Physicians · doi:10.1016/s0361-1124(76)80142-6 · Cited by 226
The fate of patients with critical leg ischemia.
Dormandy, J., Heeck, L., & Vig, S. (1999) · PubMed · Cited by 218
Gorter, P. M., Olijhoek, J. K., van der Graaf, Y., Algra, A., Rabelink, T. J., & Visseren, F. L. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.033 · Cited by 216
The pharmacology of cilostazol
Schrör, K. (2002) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.0040s2s14.x · Cited by 213
Aronow, W. S., Nayak, D., Woodworth, S., & Ahn, C. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00833-6 · Cited by 191
Rossi, E. M. C., Biasucci, L. M., Citterio, F., Pelliccioni, S., Monaco, C. G., Ginnetti, F., Angiolillo, D. J., Grieco, G., Liuzzo, G., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0702.104126 · Cited by 141
(2004) · PubMed · Cited by 118
Hämäläinen, H., Rönnemaa, T., Halonen, J.-P., & Toikka, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00523.x · Cited by 95
Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men
Planas, A., Clarà, A. B. I., Pou, J.-M., Vidal-Barraquer, F., Gasol, A., Moner, A. D., Contreras, C., & Marrugat, J. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801638 · Cited by 82
Athyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Didangelos, T., Ganotakis, E. S., Symeonidis, A. N., Daskalopoulou, S. S., Kakafika, A. I., & Elisaf, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x5599 · Cited by 81
Update on peripheral vascular diseases: from smoking cessation to stenting.
Mukherjee, D., & Yadav, J. S. (2001) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.68.8.723 · Cited by 30
Cui, R., Iso, H., Yamagishi, K., Tanigawa, T., Imano, H., Ohira, T., Kitamura, A., Sato, S., & Shimamoto, T. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000209818.36067.51 · Cited by 26
Evidence-based management of peripheral vascular disease
Shammas, N. W., & Dippel, E. J. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0047-8 · Cited by 25
Self-citation
Cited by
Binus, A. M., Qureshi, A. A., Li, V. W., & Winterfield, L. S. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10565.x · Cited by 404
Varu, V. N., Hogg, M. E., & Kibbe, M. R. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.08.073 · Cited by 362
Brickman, A. M., Provenzano, F. A., Muraskin, J., Manly, J. J., Blum, S., Apa, Z., Stern, Y., Brown, T. R., Luchsinger, J. A., & Mayeux, R. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1527 · Cited by 257
Systematic in vitro comparison of decellularization protocols for blood vessels
Simsa, R., Padma, A. M., Heher, P., Hellström, M., Teuschl, A., Jenndahl, L., Bergh, N., & Fogelstrand, P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209269 · Cited by 115
Metadata
- Authors
- Shammas, N. W.
- Venue
- Vascular Health and Risk Management
- Publisher
- Informa UK Limited
- Published
- 2007-04
- Volume
- 3
- Issue
- 2
- Pages
- 229-234
- ISSN
- 1176-6344 (ISSN-L)
- OpenAlex
- W2089538662
- Cited by
- 315
- References
- 36
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.